Ep. 2 Dr Stephen Robinson on manufacturing medicines for NTDs episode artwork

EPISODE · Mar 11, 2026 · 51 MIN

Ep. 2 Dr Stephen Robinson on manufacturing medicines for NTDs

from The DNDi podcast · host DNDi

'The color of a tablet seems like a trivial thing, but it is not.'Tune in to our in-depth conversation with Dr Stephen Robinson, Pharmaceutical Development Director at DNDi.Stephen oversees all Chemistry, Manufacturing and Control (CMC) work for both DNDi and our sister organization GARDP. In this interview, he talks in particular about zoliflodacin, a newly registered antibiotic for gonorrhea developed by GARDP; about acoziborole, a new single-dose oral treatment for sleeping sickness developed by DNDi; and explains why CMC is a shared resource between GARDP and DNDi.More information on dndi.orgContact us: [email protected] Introductory music: Maputo Queen by Etienne de la Sayette. Reproduced with the kind permission of the artist.

Episode metadata supplied by the publisher feed · Published Mar 11, 2026

Embed this episode

NOW PLAYING

Ep. 2 Dr Stephen Robinson on manufacturing medicines for NTDs

0:00 51:15

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The DNDi podcast?

This episode is 51 minutes long.

When was this The DNDi podcast episode published?

This episode was published on March 11, 2026.

Can I download this The DNDi podcast episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!